Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma

What This Study Showed

A multi-center prospective study evaluated a structured ERAS pathway for children undergoing abdominal neuroblastoma resection 0:03. The protocol incorporated 20 evidence-based elements across the perioperative continuum: preoperative counseling, hydrate loading, standardized multimodal analgesia, early feeding, and early mobilization 0:13 0:13.

Length of stay decreased from 7 days to 3.7 days 0:28. Postoperative opioid consumption dropped by over half 0:32. Patients resumed regular diets and ambulated approximately 3 days earlier 0:32. The proportion experiencing any postoperative complication decreased by over 50% 0:39. Time to clearance for adjuvant chemotherapy shortened from 10 days to 8 days 0:46.

Clinical Implications

These outcomes demonstrate that structured perioperative optimization produces measurable benefit even in complex oncologic resections 0:51. The complication reduction is particularly notable — halving morbidity in this population represents a substantial safety improvement alongside the efficiency gains.

The earlier chemotherapy clearance matters for disease control. A 2-day reduction may seem modest, but in high-risk neuroblastoma where treatment intensity and timing affect survival, any delay carries weight. The ERAS framework appears to accelerate physiologic recovery enough to maintain oncologic momentum.

What This Changes

For centers performing neuroblastoma resections, this represents a tangible opportunity to standardize perioperative care 0:51. The 20-element protocol is defined and reproducible. The outcomes — shorter stays, less opioid exposure, fewer complications, faster return to systemic therapy — align with what matters to patients, families, and oncologists.

The study does not address which protocol elements drive the benefit or whether all 20 are necessary. It demonstrates that the bundle works. Implementation will require coordination across surgery, anesthesia, nursing, and oncology, but the magnitude of improvement justifies that effort.

What This Study Evaluated

A multi-center prospective study tested whether a structured Enhanced Recovery After Surgery (ERAS) pathway could improve outcomes for children undergoing abdominal neuroblastoma resection 0:03. The protocol incorporated 20 evidence-based elements across the perioperative period, including preoperative counseling, hydrate loading, standardized multimodal analgesia, early feeding, and early mobilization [c2, c3].

Primary Outcomes

Length of stay decreased from approximately 7 days to 3.7 days 0:28. Postoperative opioid use dropped by over half 0:32. Patients resumed regular diets and ambulated about 3 days earlier than historical controls 0:32. Most notably, the proportion of patients experiencing any postoperative complication decreased by over 50% 0:39.

Patients were cleared to resume adjuvant chemotherapy earlier—at around 8 days rather than 10 days 0:46. This matters in a disease where treatment intensity and timing drive outcomes.

Clinical Implications

For trainees managing oncologic surgical patients, this demonstrates that structured perioperative protocols can meaningfully improve recovery even after complex tumor resections 0:51. Neuroblastoma resection often involves extensive dissection around major vessels and retroperitoneal structures; the fact that ERAS elements reduced complications in this population suggests the approach is robust across surgical complexity.

The protocol represents a tangible opportunity to standardize perioperative care for neuroblastoma resection 0:51. The elements are not novel individually—early feeding, multimodal analgesia, and early mobilization are established principles—but their systematic application as a bundle appears to drive the benefit. The challenge in implementation is adherence: ERAS protocols require coordination across surgery, anesthesia, nursing, and family education, and outcomes depend on executing the full pathway rather than cherry-picking components.

What This Changes

If you are rotating on pediatric surgical oncology, expect to see ERAS elements incorporated into care plans for neuroblastoma resections. Understand that the goal is not just shorter stay but earlier return to systemic therapy with fewer complications interrupting treatment. When a patient is ambulating on postoperative day one or tolerating diet on day two, that is protocol-driven, not coincidence.

What This Study Found

A multi-center prospective study evaluated a structured ERAS pathway for children undergoing abdominal neuroblastoma resection 0:03. The protocol incorporated 20 evidence-based elements spanning the entire perioperative process, including preoperative counseling, hydrate loading, standardized multimodal analgesia, early feeding, and early mobilization 0:13 0:13.

The results were substantial. Length of stay decreased from about 7 days to 3.7 days 0:28. Postoperative opioid use dropped by over half 0:32, and patients resumed regular diets and ambulated about 3 days earlier 0:32. Most notably, the proportion of patients experiencing any postoperative complication decreased by over 50% 0:39. Patients were also cleared to resume adjuvant chemotherapy earlier — at around 8 days as opposed to 10 days 0:46.

Clinical Implications

These findings demonstrate that a structured ERAS pathway meaningfully improves recovery even after complex neuroblastoma resections 0:51. The protocol represents a tangible opportunity to standardize perioperative care for this patient population 0:51.

For clinicians managing children with neuroblastoma, this study offers evidence that systematic implementation of ERAS principles — not just selective adoption of individual elements — produces measurable improvements across multiple recovery metrics. The reduction in complications and the earlier clearance for adjuvant chemotherapy are particularly relevant, as delays in resuming oncologic treatment can affect overall outcomes in high-risk disease.

The study's multi-center design suggests these results are reproducible across different institutions, making ERAS adoption a practical quality-improvement target for pediatric surgical oncology programs.